NEWS

April 23, 2025

Xeureka begins AI drug discovery research support on constrained peptides with FunPep

READ MORE

December 23, 2024

Xeureka Held the Second Executive Board Meeting of Tokyo-1

READ MORE

November 21, 2024

Sponsored Session at the CBI Annual Meeting 2024: “Accelerating Drug Discovery Innovation in the Tokyo-1 Community: The Future of Drug Discovery Unlocked by Cutting-Edge GPU Computing”

READ MORE

November 18, 2024

Our CTO, Hiroki Makiguchi, Takes the Stage at BioJapan-Hosted Seminar: “The AI Revolution in Drug Discovery”

READ MORE

August 21, 2024

Notice of Address Change

READ MORE

August 07, 2024

Xeureka begins AI drug discovery support for FunPep research on antibody-inducing peptides

READ MORE

May 02, 2024

【Case study】Target Analysis

READ MORE

March 28, 2024

Xeureka Held the First Executive Board Meeting of Tokyo-1

READ MORE

February 01, 2024

Mitsui & Co. Subsidiary, Xeureka, Launches Tokyo-1 Project Propelling AI-Driven Drug Discovery

READ MORE